Skip to content

Cognitive Behavioral Sleep Intervention for Prevention of Type 2 Diabetes

A Pilot Study of a Cognitive Behavioral Sleep Intervention for the Prevention of Type 2 Diabetes

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04457440
Enrollment
36
Registered
2020-07-07
Start date
2020-07-01
Completion date
2021-12-30
Last updated
2021-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, PreDiabetes, Sleep Deprivation

Keywords

Cognitive Behavioral Therapy, Lifestyle Intervention

Brief summary

The proposed study aims to evaluate if improving sleep could enhance the intensive lifestyle intervention for improving weight loss and glycemic control in prediabetic individuals who have insomnia with short sleep duration. A cognitive behavioral intervention for insomnia with adjustments aimed at increasing sleep duration (CBT-Sleep) will be used for this study.

Interventions

BEHAVIORALIntensive Lifestyle Intervention

This intervention is an abbreviated version of the Diabetes Prevention Program, which has been shown to be effective in reducing the risk of developing type 2 diabetes.

BEHAVIORALIntensive Lifestyle Intervention enhanced with Cognitive Behavioral Sleep Intervention

This intervention will consist of the same 8 sessions of ILI with additions of sleep components in each session. The additional sleep components will include (a) psychoeducation about the importance of sleep in weight control and glycemic control, (b) sleep hygiene, (c) stimulus control, (d) modifying maladaptive beliefs about sleep, (e) and, setting individualized sleep schedule and reviewing sleep schedule.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* (a) Hong Kong residents, * (b) BMI \> 23kg/m2, * (c) aged 18 to 65 year-old, * (d) have prediabetes, defined by a plasma fasting glucose concentration of 5.6 to 6.9 mmol/L, impaired glucose tolerance (2hglucose 7.8-11.0 on OGTT), or HbA1c 5.7-6.4%, * (e) have average habitual sleep duration \< 6.5 hours, confirmed by actigraphy measure of sleep for 2 weeks or have insomnia, confirmed in a clinical sleep interview and actigraph-measure of greater than 30 minutes of sleep onset latency or nighttime awakening for 3 nights or more per week

Exclusion criteria

* (a) have unmanaged sleep apnea or other sleep disorders, * (b) have any current severe mental illnesses, * (c) have any medical conditions or medication use that could undermine the efficacy of the sleep intervention, * (d) have shift work schedules, * (e) have any environmental constraints on the feasibility of implementing a sleep schedule of at least 7.5 hours

Design outcomes

Primary

MeasureTime frame
Changes in HbA1C (%)12 weeks from baseline
Changes in fasting glucose concentration (mg/dl)12 weeks from baseline
Changes in 2-hr oral glucose tolerance (mg/dl)12 weeks from baseline

Secondary

MeasureTime frameDescription
Changes in insomnia symptom severity12 weeks from baselinemeasured by the Insomnia Severity Index. The score ranges from 0 to 28. The higher the score, the greater the symptom severity
Changes in subjective sleep onset latency12 weeks from baselinemeasured by daily sleep diary
Changes in subjective wake after sleep onset12 weeks from baselinemeasured by daily sleep diary
Changes in subjective total sleep time12 weeks from baselinemeasured by daily sleep diary
Changes in objective sleep onset latency12 weeks from baselinemeasured by actigraphy
Changes in objective wake after sleep onset12 weeks from baselinemeasured by actigraphy
Changes in acceptance of physical activity12 weeks from baselineMeasured by the Physical Activity Acceptance and Action Questionnaire. The score ranges from 10 to 70. The higher the score, the greater acceptance.
Changes in body weight (kg)12 weeks from baseline
Changes in psychological distress12 weeks from baselinethe validated Chinese version of the Depression Anxiety Stress Scales (DASS-21)will be used. The score ranges from 0 to 63. The higher the score, the greater the distress
Changes in quality of life12 weeks from baselinethe validated Chinese version of the Satisfaction with Life Scale will be used to measure quality of life. The score ranges from 5 to 35. The higher the score, the greater the quality of life
Changes in food craving12 weeks from baselineMeasured by the Food Craving Questionnaire. The score ranges from 10 to 70. The higher the score, the greater the food craving
Changes in dietary composition12 weeks from baselineMeasured by the Chinese version of the 7-day Food Frequency Questionnaire
Changes in objective total sleep time12 weeks from baselinemeasured by actigraphy
Changes in weight loss self efficacy12 weeks from baselineMeasured by the Weight Loss Self Efficacy Scale. The score ranges from 0 to 100%. The higher the percentage, the greater the self-efficacy
Changes in weight control strategies12 weeks from baselineMeasured by the Weight Control Strategy Scale. The score ranges from 0 to 120. The higher the percentage, the more effective strategies are used

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026